COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 6 FDA records to the applicant name JenaValve Technology, Inc.. It includes 1 original PMA approval. 2 entries are PMA supplements. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 17, 2026 to Oct 13, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NPT appears in 6 of the 6 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P250024, with 6 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 3 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 4 Cromwell, Irvine, CA, 92618. Recorded on P250024/S005, decision dated Oct 13, 2026.
Device categories in this collection
Aortic Valve, Prosthesis, Percutaneously Delivered.
Changes described in PMA records
The FDA record for P250024/S005, dated 2026-10-13, is a 30-Day Notice under the Trilogy Transcatheter Heart Valve System PMA, filed by JenaValve Technology, Inc. The supplement reason is Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the stated change is "an additional abattoir for sourcing pericardium tissue." The device category is a percutaneously delivered aortic valve prosthesis (product code NPT).
Because the record names P250024, this submission modifies the existing PMA rather than granting approval of the whole system; the decision is logged as OK30, and the notice concerns a supplier arrangement for pericardium tissue sourcing. The supplied fields do not identify the abattoir, its location, tissue acceptance criteria, or any verification data tied to the added source. The stated purpose of the notice is not evidence of safety or clinical effectiveness.
FDA approval-order wording
an additional abattoir for sourcing pericardium tissue
Oct 13, 2026 · 30-Day NoticeThe supplied record describes PMA supplement P250024/S006 for the Trilogy Transcatheter Heart Valve System, applicant JenaValve Technology, Inc., with a decision dated 2026-10-07 and a designation shown as OK30. The supplement is a 30-Day Notice under the reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier," and the statement gives its scope as "an alternate supplier for delivery catheter components." The device category is an aortic valve prosthesis delivered percutaneously, product code NPT, specialty Cardiovascular.
The identifier links this supplement to original PMA P250024, so the action amends manufacturing arrangements within that approved filing rather than constituting approval of the whole system. The statement does not identify the alternate supplier, the specific components affected, the prior supplier, or the date any change takes effect; it also does not report safety or clinical effectiveness findings, and the OK30 designation is not explained in the supplied fields.
FDA approval-order wording
an alternate supplier for delivery catheter components
Oct 7, 2026 · 30-Day NoticeFDA’s recorded scope: a modification to the receiving inspection sampling plan for delivery system components
Jul 9, 2026 · 30-Day NoticeFDA’s recorded scope: approval for the protocol for the Continued Follow-up of the Premarket Cohort post-approval study (PAS)
May 18, 2026 · Normal 180 Day Track No User FeeFDA’s recorded scope: approval for the protocol for the Registry-Based Real-World Use Surveillance post-approval study (PAS)
May 18, 2026 · Normal 180 Day Track No User FeeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.